H.R. 5526 · 109th Congress
Stem Cell Research bill
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
BartlettSponsor17 cosponsors · 2 D, 15 R
R
Gingrey
KC
R
Conaway
GG
R
Gutknecht
MG
R
Green
GM
R
Miller
MM
R
Musgrave
KM
R
Marchant
JM
D
Marshall
CB
R
Boustany
WJ
D
Jefferson
ZW
R
Wamp
JK
R
Kingston
BB
R
Beauprez
TP
R
Price
DL
R
Lungren
TP
R
Petri
CP
R
Pickering1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Alternative Pluripotent Stem Cell Therapies Enhancement Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved…
What it does: CRS summary · Introduced in House · Jun 6, 2006
Alternative Pluripotent Stem Cell Therapies Enhancement Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but are not derived from a human embryo.
Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Alternative Pluripotent Stem Cell Therapies Enhancement Act
Latest action (Jul 11, 2006): Sponsor introductory remarks on measure. (CR H5036-5038, H5041-5042)
Policy area: Health · Origin: House · Introduced: Jun 6, 2006
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML) · Embed in your story
No recorded floor vote found.